2nd Artificial Intelligence in Infectious Diseases Workshop 2025
Rasha Abdelsalam Elshenawy
PhD, MSc Clinical Pharmacy, BPharm, BCPS, PgDipPP, PgDipQI, Post-Grad Dip (Ed), FRSPH
AMR/AMS Global Health Policy Expert, Consultant in AMR and Stewardship, South Centre, Geneva, Switzerland / Department of Medicine, University of Hertfordshire, United Kingdom
Biography
Dr Rasha Abdelsalam Elshenawy is a Consultant of Antimicrobial Resistance at the South Centre (Geneva, Switzerland), where she develops global policy frameworks for United Nations Member States and collaborates with the World Health Organization on antimicrobial stewardship (AMS) implementation. She is also the Director of the Antimicrobial Stewardship School (FADIC, UK) and a Senior Lecturer in Postgraduate Medicine at the University of Hertfordshire (UK), leading research that informs global health policy across more than 55 countries. Her GUIDE Framework for Evidence-Based Antibiotic Prescribing is being adopted internationally through WHO partnerships. Dr Elshenawy serves as Associate Editor for JAC – Antimicrobial Resistance (Oxford University Press) and has authored over 150 research outputs on AMR, AMS, digital health innovation, and health systems strengthening. Her work directly advances the UN Sustainable Development Goals and the global fight against antimicrobial resistance.
RELATED MATERIALS
RELATED COURSES

CME Series | Implementing AI in Infectious Disease Management
The advantages and limitations of AI-based tools for supporting early diagnosis and decision-making are becoming increasingly recognized in clinical practice. In the first lecture, you will learn how AI can support early patient screening and risk stratification in antimicrobial resistance (AMR) stewardship.
The second lecture focuses on ways to leverage AI to perform a multi-center analysis on microbiology data. It provides insights into the benefits of collaboration among different centers, challenges to data sharing and analysis, and optimal strategies for the implementation of existing AI-based solutions.
What Will Set You Apart?
After following this educational series, participants will be able to:
- Define strategies for early detection and risk stratification to ensure timely, evidence-based antimicrobial prescription
- Analyse the role of AI in early detection and real-time monitoring to support decision-making in clinical practice
- Discuss the advantages of multi-center mircobiologic analysis in understanding microbe epidemiology, their spread, and defining populations at increased risk
- Summarise technological pillars required for complex data analyses involving multiple healthcare centers
Is This Program for You?
This program is designed for clinicians, residents, pharmacists, researchers, and healthcare teams involved in the implementation of AI technology.
What Will You Cover in This Module?
- AI in early detection, risk stratification and antimicrobial stewardship
- AI for multi-center microbiologic analyses
- AI implementation in healthcare systems